Inventor
Caldwell richard d
US26 patents
⚠️ This page may combine multiple inventors who share the name “Caldwell richard d”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BIOGEN MA INC
10 patentsUS9186367B2Nov 17, 2015
Bicyclic aryl sphingosine 1-phosphate analogs
BIOGEN MA INC15 citations91
US10166250B2Jan 1, 2019
Bicyclic aryl sphingosine 1-phosphate analogs
BIOGEN MA INC9 citations84
US9827258B2Nov 28, 2017
Bicyclic aryl sphingosine 1-phosphate analogs
BIOGEN MA INC8 citations84
US9572824B2Feb 21, 2017
Bicyclic aryl sphingosine 1-phosphate analogs
BIOGEN MA INC10 citations84
US10034869B2Jul 31, 2018
S1P modulating agents
BIOGEN MA INC2 citations73
US9808449B2Nov 7, 2017
S1P modulating agents
BIOGEN MA INC2 citations73
US10894040B2Jan 19, 2021
S1P modulating agents
BIOGEN MA INC0 citations62
US10406144B2Sep 10, 2019
SIP modulating agents
BIOGEN MA INC0 citations52
US10081646B2Sep 25, 2018
Heterobicyclic sphingosine 1-phosphate analogs
BIOGEN MA INC0 citations52
US9708353B2Jul 18, 2017
Heterobicyclic sphingosine 1-phosphate analogs
BIOGEN MA INC0 citations52
MERCK PATENT GMBH
10 patentsUS10329270B2Jun 25, 2019
Heteroaryl compounds as BTK inhibitors and uses thereof
MERCK PATENT GMBH16 citations83
US10266528B2Apr 23, 2019
2-oxo-imidazopyridines as reversible BTK inhibitors and uses thereof
MERCK PATENT GMBH3 citations73
US10005784B2Jun 26, 2018
Pyridines, pyrimidines, and pyrazines, as BTK inhibitors and uses thereof
MERCK PATENT GMBH2 citations72
US9738648B2Aug 22, 2017
Pyridines, pyrimidines, and pyrazines, as BTK inhibitors and uses thereof
MERCK PATENT GMBH2 citations72
US10253023B2Apr 9, 2019
Heteroaryl compounds as BTK inhibitors and uses thereof
MERCK PATENT GMBH3 citations71
US10493073B2Dec 3, 2019
Heteroaryl compounds as BTK inhibitors and uses thereof
MERCK PATENT GMBH1 citations62
US11098041B2Aug 24, 2021
Heteroaryl compounds as BTK inhibitors and uses thereof
MERCK PATENT GMBH1 citations61
US10045985B2Aug 14, 2018
Heteroaryl compounds as BTK inhibitors and uses thereof
MERCK PATENT GMBH0 citations51
US12415803B2Sep 16, 2025
Fused imidazopyridines as reversible inhibitors of Brutons Tyrosine Kinase (BTK)
MERCK PATENT GMBH0 citations50
US10012650B2Jul 3, 2018
Assays for BTK inhibitors
MERCK PATENT GMBH0 citations43